Rx Reimbursement Law In Iowa Limits Cost Control, PBM Suit Argues
This article was originally published in The Pink Sheet Daily
Executive Summary
Pharmaceutical Care Management Association say that new Iowa law would limit number of generic drugs for which PBMs could set “maximum allowable cost” prices and unconstitutionally require firms to divulge proprietary drug pricing information to state.